Skip to content
MarketScale
‹ Back to Industries

Sciences

The Negative Public Perception of Nuclear Energy is Posing More Risks Than Its Actual Threat

Despite being in the age of information, misinformation can often cast a longer shadow especially pertaining to the perception of nuclear energy. Even with its green credentials and immense potential for reducing carbon emissions, nuclear power struggles with public perception. Currently, there are a lot of fears and misinformation with Japan’s release of…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Nick Loris · AsiaC3 SolutionsFukushimaJapan
Share

Key takeaways

01

Despite being in the age of information, misinformation can often cast a longer shadow especially pertaining to the perception of nuclear energy.

02

Even with its green credentials and immense potential for reducing carbon emissions, nuclear power struggles with public perception.

03

Currently, there are a lot of fears and misinformation with Japan’s release of…

Despite being in the age of information, misinformation can often cast a longer shadow especially pertaining to the perception of nuclear energy. Even with its green credentials and immense potential for reducing carbon emissions, nuclear power struggles with public perception. Currently, there are a lot of fears and misinformation with Japan’s release of treated wastewater from the Fukushima power plant. This is a move scientifically deemed as extremely low risk

Yet, countries like China, Taiwan, and South Korea have continued to ban the importation of seafood from Japan, stoking the fire of public anxiety that already disproportionately dwarfs the actual risk involved. Adding to the growing list of countries with concerns, Russia has added its voice to the conversation.

This discord between perception and reality could cripple efforts to diversify energy portfolios and meet several crucial goals. Even on the precipice of environmental disaster, it is vital that fact-based discourse leads the way. Without it there will be risk of forsaking one of the most efficient and safest forms of energy at disposal. If climate change is to be combatted while ensuring energy security, there needs to be a reevaluation of collective consciousnesses that surrounds nuclear power.

As the Vice President of Public Policy at C3 Solutions, Nick Loris has the knowledgeable expertise on the energy debate. With a focus on free-market environmentalism, Loris’ work seeks to navigate the complex interplay between public policy, energy resources, and environmental protection. This knowledge enables him to elaborate on where misinformation can interfere with the perception of nuclear energy and the future of its research.

Loris’ Thoughts

“What we’re seeing in response from places like China and Taiwan and South Korea in terms of continuing to ban the importation of seafood from Japan is emblematic of the larger problem with nuclear power, and that is that the public perception of risk is far greater than the actual risk. Japan’s release of wastewater from the Fukushima power plant into the ocean is extremely safe and extremely low risk. The water has been treated multiple times, and the level of radioactivity is far below any limits set and will pose negligible impacts on human health and the environment. 

“In fact, the level of radioactivity is only about two percent of what the limit is for safe drinking water set by the World Health Organization. What we’re seeing in response from places like China and Taiwan and South Korea in terms of continuing to ban the importation of seafood from Japan is emblematic of the larger problem with nuclear power, and that is that the public perception of risk is far greater than the actual risk. The reality is nuclear power is among the cleanest and safest forms of energy that we have on the planet today, and if we are to meet our needs in terms of providing affordable, reliable energy and meeting our emissions targets to reduce the effects and impacts of climate change, nuclear power will play an integral role in accomplishing both.”

Article written by Alexandra Simon.

About the author

Nick Loris
Nick LorisVice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Nick Loris
Nick Loris

Vice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).